Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2021-10-08
2022-04-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to describe the changes in muscle strength, muscle size, corticospinal excitability, voluntary activation, M1 cortical thickness, and resting state functional connectivity following a 2-week limb immobilization period in young women.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Agonist and Antagonist Muscle Activations in the Lower Limbs During Walking After Central Nervous System Injury
NCT06107556
Novel Intervention to Influence Muscle Plasticity in Veterans
NCT01093014
Assessment of Cortical Plasticity Following Short Term Limb Immobility
NCT00647374
Effects of an Eccentric Muscle Strengthening Protocol on Force Moment, Muscle Activation and Plantar Flexor Structure of Patients With Central Nervous System Injuries.
NCT06099340
Mental Practice Impact on Gait and Cortical Organization in Spinal Cord Injury (SCI)
NCT01302522
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immobilized arm
Left arm of participant
Immobilization
Immobilization of left arm using a brace and sling.
Non-immobilized arm
Right arm of participant
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immobilization
Immobilization of left arm using a brace and sling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Right-hand dominant
* Body mass index between 18.5-30 kg/m\^2 (inclusive)
* Regular menstrual cycle
* Be able to maintain a habitual diet throughout the duration of the study
Exclusion Criteria
* Pregnancy
* A history of brain trauma
* Suffers from a neurological disease or movement disorder
* Peripheral nerve damage
* Use of medications known to affect protein metabolism (i.e., corticosteroids, non-steroidal anti-inflammatory drugs, or prescription strength acne medications)
* Diagnosed with or suspects having a psychiatric illness
* Use of dietary supplements known to affect muscle size (i.e., creatine, fish oil)
* Past or present diagnosis of an eating disorder by a physician or registered dietician
* Possesses any metal implants (e.g. artificial joints, pacemakers, stents) or non-removeable medical devices that are contraindicative for magnetic resonance imaging (e.g. insulin pumps)
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tyler Churchward-Venne
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Exercise Metabolism and Nutrition Research Laboratory
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
A00-M01-21A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.